1. Merck Frosst Canada, Inc. (16 from 212 patents)

2. Merck Frosst Canada & Co. (9 from 76 patents)

3. Merck Sharp + Dohme Corp. (5 from 2,405 patents)

4. Merck Canada Inc. (5 from 40 patents)

5. Institut National De La Recherche Scientifique (3 from 123 patents)

6. Hydro-quebec (2 from 459 patents)

7. National Research Council of Canada (1 from 1,012 patents)

1. 10189084 - Method and system for fabrication of hydrogen-permeable membranes

2. 9745295 - Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors

3. 9586931 - Triazolyl derivatives as Syk inhibitors

4. 9353066 - Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors

5. 9242984 - Pyrazolyl derivatives as Syk inhibitors

6. 9108843 - Method and system for preparation of highly porous and preferentially-oriented {100} platinum nanowires and thin films

7. 8551984 - Aminopyrimidines as SYK inhibitors

8. 8470410 - Method and system for producing electrocatalytic coatings and electrodes

9. 7622501 - Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclooxygenase-2 inhibitors

10. 7144913 - Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists

11. 7019022 - Substituted tetrahydrocarbazole and cyclopentanoindole derivatives

12. 6841564 - Tri-aryl-substituted-ethane PDE4 inhibitors

13. 6743802 - Alkyne-aryl phosphodiesterase-4 inhibitors

14. 6680042 - Method of rapidly carrying out a hydrogenation of a hydrogen storage material

15. 6677351 - 1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors